Light

Matta et al. demonstrated in a randomised trial that all six tested sunscreen active ingredients exceeded the FDA safety threshold of 0.5 ng/mL in plasma on the first day of application. Oxybenzone reached systemic levels within two hours. The skin acts as a depot, with ingredients detectable in blood for up to 21 days after application ceased.

CDC NHANES testing detected oxybenzone in 97% of the US population sampled. Krause et al. reviewed the endocrine activity of UV filter chemicals, finding 8 of 9 showed oestrogenic activity in cell assays and 6 of 9 increased uterine weight in immature rats. Oxybenzone functions as an oestrogen receptor agonist, androgen receptor antagonist and thyroid receptor agonist simultaneously.

Rhodes et al. supplemented participants with fish oil for three months and found the minimal erythemal dose of UVB increased by approximately seventy percent, meaning significantly more UV was needed to cause sunburn. UV-induced PGE₂ in skin fell by over 60%. A separate double-blind RCT using purified EPA showed an 8-fold increase in epidermal EPA content and a 36% rise in sunburn threshold.

The mechanism is direct: UV activates phospholipase A2, which liberates arachidonic acid from cell membranes and COX-2 converts this to PGE₂, the primary inflammatory mediator of sunburn. Omega-3 fatty acids compete for these enzymes, producing less inflammatory eicosanoids. A diet heavy in omega-6 loads the membrane with more substrate for this inflammatory cascade.

Webb et al. demonstrated that at latitudes above 51°N the solar zenith angle from October to March is too acute for sufficient UVB radiation to reach the skin surface. London sits at 51.5°N. For six months of the year, regardless of time spent outdoors, cutaneous vitamin D synthesis is effectively zero.

At Boston (42°N) the vitamin D winter lasts four months, while at 34°N synthesis occurs year-round. Cloud cover and air pollution at UK latitudes further reduce the already limited UVB window during the remaining months. This is a geographical constraint, not a lifestyle choice.

Myerson (1939) exposed the torso skin of male subjects to UV radiation and measured a 120% increase in circulating testosterone. When UV exposure was applied to the genital area, testosterone levels rose by approximately 200%. These experiments, conducted decades before the obesity and seed oil epidemics, demonstrated a direct photoneuroendocrine effect of UV radiation on steroidogenesis independent of vitamin D status.

Parikh et al. (2021) published in Cell Reports confirming the mechanism in modern terms: UVB exposure on skin activates the hypothalamic-pituitary-gonadal axis via p53-dependent β-endorphin release from keratinocytes. This skin-brain-gonad pathway operates independently of the visual system. The same UV spectrum that synthesises vitamin D simultaneously signals the reproductive axis. Testosterone, LH and sexual behaviour all increased in UV-exposed mice, effects abolished by conditional p53 knockout in skin.

Modern men cover 90% or more of their skin with clothing, apply UV-blocking sunscreen to what remains, work behind UV-filtering glass and spend 93% of their day indoors. The testosterone decline of 1% per year documented by Travison et al. coincides precisely with the shift to indoor living. The endocrine system is receiving a UV signal that is a tiny fraction of what it was calibrated for.

Liu et al.'s RCT irradiated volunteers with UVA and found a two and a half millimetre of mercury reduction in mean arterial blood pressure lasting about sixty minutes, attributed to UVA-induced release of nitric oxide from skin stores into the circulation.

Nitric oxide is a potent vasodilator and this UVA-mediated pathway operates independently of vitamin D synthesis, which requires UVB rather than UVA. The finding means sun avoidance carries a cardiovascular cost that cannot be corrected by vitamin D supplementation alone.

Blood pressure is the strongest single modifiable predictor of cardiovascular mortality. A sustained 2.5 mmHg reduction at a population level would prevent tens of thousands of strokes and heart attacks annually. The public health advice to minimise sun exposure is not priced against this benefit.

Hossein-nezhad et al. (2013) gave healthy adults either 400 IU or 2,000 IU of vitamin D3 daily for two months and performed genome-wide expression profiling on white blood cells before and after. The higher dose significantly altered the expression of 291 genes (229 unique), affecting pathways including immune response, DNA repair, oxidative stress, apoptosis and cell cycle control. Many of these genes are implicated in autoimmune disease, cardiovascular disease, diabetes and cancer.

This is because vitamin D is not a nutrient in the conventional sense. It is a steroid hormone precursor that, once hydroxylated in the liver and kidneys, binds the vitamin D receptor (VDR), a nuclear transcription factor. VDR binding sites exist across approximately 2,776 genomic positions, regulating roughly 3% of the human genome. Supplementation at therapeutic doses (raising serum 25(OH)D above 75 nmol/L) produced measurably different gene expression compared to sub-therapeutic doses, even within 8 weeks.

The sun does not merely warm the skin. Through the vitamin D pathway alone, it controls the expression of hundreds of genes governing the immune system, DNA repair, inflammation and cell proliferation. Every hour spent indoors is an hour these genes go unregulated.

Urashima et al. (2010, American Journal of Clinical Nutrition) randomised 334 schoolchildren to receive 1,200 IU/day of vitamin D3 or placebo during winter. Influenza A incidence was forty-two per cent lower in the vitamin D group (RR 0.58, 95% CI 0.34 to 0.99). In the subgroup of children who had not previously taken vitamin D supplements, the reduction was sixty-four per cent (RR 0.36, 95% CI 0.17 to 0.79). Asthma attacks were also reduced by eighty-three per cent in the supplementation group.

This is because vitamin D (produced in the skin by UVB radiation) is converted to its active form 1,25-dihydroxyvitamin D3, which binds the vitamin D receptor expressed on virtually all immune cells. In innate immunity, it induces cathelicidin and beta-defensin antimicrobial peptides. In adaptive immunity, it suppresses Th1 pro-inflammatory cytokines and promotes Th2 and regulatory T cell responses. Liu et al. (2006, Science) demonstrated that vitamin D activation of cathelicidin was essential for macrophage killing of Mycobacterium tuberculosis.

An estimated one billion people worldwide have vitamin D deficiency (Holick, 2007, NEJM). The vitamin D supplement market reached $1.2 billion in 2023 (Grand View Research). Fifteen minutes of midday sun exposure on arms and legs produces approximately 10,000 to 20,000 IU of vitamin D3, more than any standard supplement dose, at no cost. Sun avoidance guidelines contribute directly to the deficiency they then recommend supplements to address.

Scheer and Buijs (1999, Journal of Biological Rhythms) demonstrated that bright morning light (>2,500 lux) increased the cortisol awakening response by 58% compared to dim indoor light (<200 lux). Leproult et al. (2001, JCEM) showed that evening bright light shifted cortisol rhythms, delaying the nadir and flattening the diurnal curve. The HPA axis uses light as its primary zeitgeber for adrenal timing.

This is because melanopsin-containing retinal ganglion cells project directly to the suprachiasmatic nucleus, which signals the paraventricular nucleus of the hypothalamus to initiate CRH release. Morning light triggers a sharp cortisol pulse that mobilises glucose, suppresses inflammation and primes immune surveillance. Without this signal, the HPA axis free-runs, producing the flattened cortisol curve associated with chronic fatigue, depression and metabolic syndrome.

Modern humans wake to artificial light at 100 to 300 lux, receive no direct sunlight until commuting behind UV-filtered glass and spend the evening under blue-enriched LED. This inverts the natural cortisol architecture: blunted morning peak, elevated evening trough. The result is an HPA axis that never properly activates or deactivates.

Jaadane et al. (2015, Free Radical Biology and Medicine) exposed rat retinal cells to LED blue light (449nm) and found 23% more cell death compared to equivalent-intensity fluorescent light containing the same blue wavelengths embedded in a broader spectrum. Shang et al. (2014, Neuroscience) showed chronic LED blue exposure caused photoreceptor degeneration in the rat retina that broad-spectrum white light at the same intensity did not. The isolated blue wavelength is the variable, not the total light intensity.

This is because natural sunlight delivers blue wavelengths (446-484nm) alongside near-infrared (700-1400nm), which activates protective mitochondrial pathways in retinal cells. Begum et al. (2013, Age) demonstrated that near-infrared pre-conditioning protects retinal pigment epithelium against blue light-induced oxidative damage by upregulating mitochondrial membrane potential and reducing reactive oxygen species. In sunlight, the damaging and protective wavelengths arrive simultaneously. In LED lighting and screens, the protection is absent.

The human eye evolved under full-spectrum sunlight containing simultaneous UV, visible and infrared radiation for millions of years. It did not evolve under isolated 449nm blue peaks from LED backlighting. The modern "blue light epidemic" is not caused by blue light itself. It is caused by blue light stripped of the infrared protection that always accompanied it in nature.

He et al. (2015, JAMA) randomised 1,903 Chinese schoolchildren aged six to seven years to receive an additional forty minutes of outdoor activity per day or standard curriculum. After three years, myopia incidence was 30.4 per cent in the intervention group versus 39.5 per cent in the control group, a relative reduction of twenty-three per cent. The CREAM consortium meta-analysis (2015, Ophthalmology) of eight studies found that each additional hour per week of outdoor time reduced myopia risk by approximately two per cent. Rose et al. (2008, Ophthalmology, Sydney Myopia Study) found outdoor time, not physical activity, was the protective factor.

This is because bright outdoor light stimulates retinal dopamine release from amacrine cells, which acts as a stop signal for axial elongation of the eyeball. Myopia occurs when the eye grows too long for its optical power. Ashby and Schaeffel (2010, Investigative Ophthalmology) demonstrated in chick models that dopamine D2 receptor agonists prevented form-deprivation myopia, while D2 antagonists blocked the protective effect of light. The intensity threshold for protection is approximately 10,000 lux, achievable outdoors but rarely indoors.

Global myopia prevalence is projected to reach fifty per cent of the world population by 2050 (Holden et al., 2016, Ophthalmology). The corrective lens market exceeded $150 billion in 2023 (Allied Market Research). Refractive surgery generates approximately $3.4 billion annually (Market Research Future). The primary prevention, outdoor time during childhood, costs nothing and is supported by randomised evidence. The treatment industry for a preventable condition exceeds $150 billion per year.

Shang et al. (2014, Environment International) found that blue LED light (449nm peak) caused 23% greater retinal cell death than fluorescent lighting over 72 hours. The damage was dose-dependent and ROS-mediated. Nakamura et al. (2017, Scientific Reports) confirmed blue light at 450nm induced apoptosis in human retinal cells at indoor LED intensities.

This is because white LEDs are blue LEDs coated with yellow phosphor, producing a pronounced 450nm spike absent from natural light. The retina receives disproportionately more high-energy blue photons from LEDs than from sunlight or incandescent bulbs. Natural light has a broad, continuous spectrum. Incandescent emits primarily red-infrared.

The transition to LED lighting was driven by energy efficiency. No long-term retinal studies were conducted on chronic population-wide LED exposure before incandescent bulbs were phased out across the EU (2012). ICNIRP exposure limits (2020) address acute damage thresholds, not lifetime chronic exposure.

Fell et al. (2014, Cell) demonstrated that chronic low-dose UV-B exposure in mice triggered p53-mediated upregulation of the pro-opiomelanocortin (POMC) gene in keratinocytes, producing both beta-endorphin and alpha-melanocyte-stimulating hormone. Plasma beta-endorphin rose significantly, increasing pain thresholds in a response that was completely blocked by the opioid antagonist naloxone. The authors concluded that UV exposure generates a systemic opioid reward through the skin.

This is because POMC is the same precursor peptide that the pituitary gland uses to produce endorphins during exercise and stress. UV radiation activates this pathway in the skin independently, creating a parallel source of endogenous opioids. Skobowiat et al. (2011) showed that human keratinocytes express the full opioidergic apparatus: POMC, prohormone convertases, mu-opioid receptors and beta-endorphin degradation enzymes.

The evolutionary logic is precise. A species that needed to spend 10 to 14 hours daily in sunlight was given an opioid reward for doing so, identical in mechanism to the endorphin reward for physical movement. Modern indoor living removes both stimuli simultaneously: insufficient light and insufficient movement. The hedonic deficit is filled by artificial dopamine sources that provide reward without the biological calibration that sunlight and movement deliver.